FDA probes Intuitive Surgical on complication rates

March 1, 2013 by Brad Perriello

The FDA surveys doctors on complications experienced using Intuitive Surgical's da Vinci surgical robot, sending shares down on Wall Street.

Intuitive Surgical

The FDA is looking into complication rates for surgeries using Intuitive Surgical's (NSDQ:ISRG) da Vinci surgical robot, sending a survey to doctors who use the device.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp